Biogen loses CMO, neuromuscular leader; John Hood adds president, CFO at Endeavor BioMedicines

Maha Radhakrishnan

Biogen chief medical officer Maha Radhakrishnan is out after four years “as of March 1,” a spokesperson tells Peer Review. Biogen didn’t draw up a press release for her departure, but a board appointment at NYSE newcomer Alto…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks